Synthesis and stereochemical assignment of Brasilibactin A

Organic Letters

Volumn 9, Issue 9, 2007, Pages 1679-1681

  Mitchell, Judith M ^a,b   Shaw, Jared T ^a,c  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Helicos BioSciences Corporation   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 THIAZOLINETHIONE; AMIDE; BRASILIBACTIN A; ENZYME INHIBITOR; HISTONE; HISTONE DEACETYLASE; LYSINE; METAL; MYCOBACTINS; OXAZOLE DERIVATIVE; STEARIC ACID DERIVATIVE; THIAZOLIDINE DERIVATIVE; THIAZOLINE-2-THIONE; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; HYDROXYLATION; METABOLISM; STEREOISOMERISM; SYNTHESIS;

AMIDES; ENZYME INHIBITORS; HISTONE DEACETYLASES; HISTONES; HYDROXYLATION; LYSINE; METALS; MOLECULAR STRUCTURE; OXAZOLES; STEARIC ACIDS; STEREOISOMERISM; THIAZOLIDINES;

EID: 34248332635     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol070355o     Document Type: Article

References (27)

1. Suzuki, T.; Miyata, N. Curr. Med. Chem. 2006, 13, 935-958.
2. Taunton, J.; Hassig, C. A.; Schreiber, S. L. Science 1996, 272, 408-411.
3. Miller, T. A.; Witter, D. J.; Belvedere, S. J. Med. Chem. 2003, 46, 5097-5116.
4. Collins, I.; Workman, P. Nat. Chem. Biol. 2006, 2, 689-700.
5. Cloos, P. A. C.; Christensen, J.; Agger, K.; Maiolica, A.; Rappsilber, J.; Antal, T.; Hansen, K. H.; Helin, K. Nature 2006, 442, 307-311.
6. (a) Lee, M. G.; Wynder, C.; Schmidt, D. M.; McCafferty, D. G.; Shiekhattar, R. Chem. Biol. 2006, 13, 563-567.
7. (b) Culhane, J. C.; Szewczuk, L. M.; Liu, X.; Da, G.; Marmorstein, R.; Cole, P. A. J. Am. Chem. Soc. 2006, 128, 4536-4537.
8. Lee, M. G.; Wynder, C.; Bochar, D. A.; Hakimi, M.-A.; Cooch, N.; Shiekhattar, R. Mol. Cell. Biol. 2006, 26, 6395-6402.
9. (a) Bolden, J. E.; Peart, M. J.; Johnstone, R. W. Nat. Rev. Drug Discovery 2006, 5, 769-784.
10. (b) Jenuwein, T. FEBS J. 2006, 273, 3121 -3135.
11. (c) Oki, Y.; Issa, J.-P. J. Rev. Recent Clin. Trials 2006, 1, 169-182.
12. (d) Fraga, M. F.; Esteller, M. Cell Cycle 2005, 4, 1377-1381.
13. (a) Wu, T. Y. H.; Hassig, C.; Wu, Y.; Ding, S.; Schultz, P. G. Bioorg. Med. Chem. Lett. 2004, 14, 449-453.
14. (b) Nishino, N.; Yoshikawa, D.; Watanabe, L. A.; Kato, T.; Jose, B.; Komatsu, Y.; Sumida, Y.; Yoshida, M. Bioorg. Med. Chem. Lett. 2004, 14, 2427-2431.
15. Vanommeslaeghe, K.; Loverix, S.; Geerlings, P.; Tourwe, D. Bioorg. Med. Chem. 2005, 13, 6070-6082.
16. Tsuda, M.; Yamakawa, M.; Oka, S.; Tanaka, Y.; Hoshino, Y.; Mikami, Y.; Sato, A.; Fujiwara, H.; Ohizumi, Y.; Kobayashi, J. I. J. Nat. Prod. 2005, 68, 462-464.
17. (a) Vergne, A. F.; Walz, A. J.; Miller, M. J. Nat. Prod. Rep. 2000, 17, 99-116.
18. (b) A related compound (oxachelin) featuring a terminal δ-lactam was recently reported: Sontag, B.; Gerlitz, M.; Paululat, T.; Rasser, H.-F.; Gruen-Wollny, I.; Hansske, F. G. J. Antibiot. 2006, 59, 659-663.
19. Crimmins, M. T.; King, B. W.; Tabet, E. A.; Chaudhary, K. J. Org. Chem. 2001, 66, 894-902.
20. (a) Miller, M. J.; Hu, J. J. Org. Chem. 1994, 59, 4858-4861.
21. (b) Yokokawa, F.; Izumi, K.; Omata, J.; Shioiri, T. Tetrahedron 2000, 56, 3027-3034.
22. Miller, M. J.; Hu, J. J. Am. Chem. Soc. 1997, 119, 3462-3468.
23. Snow, G. Biochem. J. 1965, 94, 160-165.
24. Jalal, M. A. F.; Galles, J. L.; Van der Helm, D. J. Org. Chem. 1985, 50, 5642-5645.
25. Attempts to contact Prof. Kobayashi (ref 11) in an effort to obtain authentic material for direct comparison were unsuccessful.
26. The details of this assay will be described elsewhere: Kwiatkowski, N.; Bradner, J. E.; Greenberg, E. F.; Shaw, J. T.; Schreiber, S. L.; Mazitschek, R. Angew. Chem., Int. Ed., manuscript in preparation.
27. Compound 4 is prepared in four steps from protected lysine, making the longest linear sequence ten steps from commercially available materials.